Pharmacopolitics
(eBook)
Advocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will supersede national medical practices and result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials, and systems for monitoring adverse reactions in the United States and Germany, two countries with similarly advanced systems for medical research, testing, and patient care. Daemmrich proposes that divergent "therapeutic cultures--the interrelationships among governments, patients, the medical profession, and the pharmaceutical industry--underlie national differences and explain variations in pharmaceutical markets and medical care. Daemmrich carries the United States-Germany comparison from 1950 to the present through case studies of Terramycin (an antibiotic), thalidomide (a sedative), propranolol (a heart medication), interleukin-2 (a cancer therapy), and indinavir (an AIDS drug). He points to different political constructions of "the patient" in the United States and Germany to clarify important differences in government policies and in the distribution of power among key social actors. Daemmrich advises that international regulatory harmonization and globalization in medicine must retain flexibility for social and political variation between countries, even as they achieve technical standardization.
Notes
Daemmrich, A. A. (2005). Pharmacopolitics. [United States], The University of North Carolina Press.
Chicago / Turabian - Author Date Citation (style guide)Daemmrich, Arthur A.. 2005. Pharmacopolitics. [United States], The University of North Carolina Press.
Chicago / Turabian - Humanities Citation (style guide)Daemmrich, Arthur A., Pharmacopolitics. [United States], The University of North Carolina Press, 2005.
MLA Citation (style guide)Daemmrich, Arthur A.. Pharmacopolitics. [United States], The University of North Carolina Press, 2005.
Hoopla Extract Information
hooplaId | 11718106 |
---|---|
title | Pharmacopolitics |
kind | EBOOK |
price | 2.49 |
active | 1 |
pa | 0 |
profanity | 0 |
children | 0 |
demo | 0 |
rating | |
abridged | 0 |
dateLastUpdated | Jan 18, 2024 06:11:41 PM |
Record Information
Last File Modification Time | Nov 23, 2023 12:00:43 AM |
---|---|
Last Grouped Work Modification Time | Jan 26, 2024 03:04:47 PM |
MARC Record
LEADER | 02847nam a22003735a 4500 | ||
---|---|---|---|
001 | MWT11718106 | ||
003 | MWT | ||
005 | 20231028123602.1 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 231028s2005 xxu eo 000 0 eng d | ||
020 | |a 9780807863398|q (electronic bk.) | ||
020 | |a 0807863394|q (electronic bk.) | ||
028 | 4 | 2 | |a MWT11718106 |
029 | |a https://d2snwnmzyr8jue.cloudfront.net/csp_9780807863398_180.jpeg | ||
037 | |a 11718106|b Midwest Tape, LLC|n http://www.midwesttapes.com | ||
040 | |a Midwest|e rda | ||
099 | |a eBook hoopla | ||
100 | 1 | |a Daemmrich, Arthur A.,|e author. | |
245 | 1 | 0 | |a Pharmacopolitics|h [electronic resource] /|c Arthur A. Daemmrich. |
264 | 1 | |a [United States] :|b The University of North Carolina Press,|c 2005. | |
264 | 2 | |b Made available through hoopla | |
300 | |a 1 online resource (224 pages) | ||
336 | |a text|b txt|2 rdacontent | ||
337 | |a computer|b c|2 rdamedia | ||
338 | |a online resource|b cr|2 rdacarrier | ||
347 | |a text file|2 rda | ||
506 | |a Instant title available through hoopla. | ||
520 | |a Advocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will supersede national medical practices and result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials, and systems for monitoring adverse reactions in the United States and Germany, two countries with similarly advanced systems for medical research, testing, and patient care. Daemmrich proposes that divergent "therapeutic cultures--the interrelationships among governments, patients, the medical profession, and the pharmaceutical industry--underlie national differences and explain variations in pharmaceutical markets and medical care. Daemmrich carries the United States-Germany comparison from 1950 to the present through case studies of Terramycin (an antibiotic), thalidomide (a sedative), propranolol (a heart medication), interleukin-2 (a cancer therapy), and indinavir (an AIDS drug). He points to different political constructions of "the patient" in the United States and Germany to clarify important differences in government policies and in the distribution of power among key social actors. Daemmrich advises that international regulatory harmonization and globalization in medicine must retain flexibility for social and political variation between countries, even as they achieve technical standardization. | ||
538 | |a Mode of access: World Wide Web. | ||
650 | 0 | |a Electronic books. | |
710 | 2 | |a hoopla digital. | |
856 | 4 | 0 | |u https://www.hoopladigital.com/title/11718106?utm_source=MARC&Lid=hh4435|z Instantly available on hoopla. |
856 | 4 | 2 | |z Cover image|u https://d2snwnmzyr8jue.cloudfront.net/csp_9780807863398_180.jpeg |